Department of Orthopaedic and Trauma Surgery, Academic Hospital of Bolzano (SABES-ASDAA), 39100, Bolzano, Italy.
Department of Life Sciences, Health, and Health Professions, Link Campus University, 00165, Rome, Italy.
Eur J Orthop Surg Traumatol. 2024 Nov 23;35(1):20. doi: 10.1007/s00590-024-04135-x.
INTRODUCTION: Intra-articular injections of ozone and hyaluronic acid (HA) are routinely performed for the management of knee osteoarthritis. The present meta-analysis compared intra-articular injections of HA versus ozone in patients with knee osteoarthritis (OA) in patient-reported outcome measures (PROMs). The outcomes of interest were to determine if intra-articular ozone injections show comparable visual analogue scale (VAS) and Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) scores compared to intra-articular HA injections. METHODS: This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the 2020 PRISMA statement. In January 2024, the following databases were accessed: PubMed, Web of Science, Google Scholar, and Embase. All the randomised controlled trials (RCTs) comparing intra-articular HA versus ozone injections in patients with knee OA were accessed. Only studies which clearly stated that injections were performed in patients with knee OA were considered. Data concerning the VAS and WOMAC were retrieved at baseline and the last follow-up. Studies with a follow-up shorter than 4 months or longer than 6 months were not included. RESULTS: Data from 424 patients were collected. 74% (314 of 424 patients) were women. The mean age of the patients was 61.1 ± 4.5 years, and the mean BMI was 27.8 ± 0.8 kg/m. Compatibility was found in the mean age, mean BMI, PROMs, and the percentage of women. No difference was found in VAS at follow-up (P = 0.4). CONCLUSION: The current level I evidence suggests that ozone and HA intra-articular injections achieve similar pain control between 4 and 6 months of follow-up. LEVEL OF EVIDENCE: Level I.
简介:关节内臭氧和透明质酸(HA)注射已常规用于膝骨关节炎的治疗。本荟萃分析比较了膝关节骨关节炎(OA)患者关节内 HA 与臭氧注射的患者报告结局测量(PROM)。我们关注的结果是确定关节内臭氧注射是否与关节内 HA 注射相比具有可比的视觉模拟评分(VAS)和西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分。
方法:本研究根据系统评价和荟萃分析的首选报告项目:2020 年 PRISMA 声明进行。2024 年 1 月,检索了以下数据库:PubMed、Web of Science、Google Scholar 和 Embase。检索了所有比较膝关节 OA 患者关节内 HA 与臭氧注射的随机对照试验(RCT)。仅考虑了明确说明在膝关节 OA 患者中进行注射的研究。检索了基线和最后随访时的 VAS 和 WOMAC 数据。未纳入随访时间短于 4 个月或长于 6 个月的研究。
结果:共收集了 424 名患者的数据。74%(424 名患者中的 314 名)为女性。患者的平均年龄为 61.1±4.5 岁,平均 BMI 为 27.8±0.8 kg/m。平均年龄、平均 BMI、PROM 和女性百分比具有可比性。在随访时 VAS 无差异(P=0.4)。
结论:目前的 I 级证据表明,臭氧和 HA 关节内注射在 4 至 6 个月的随访中具有相似的疼痛控制效果。
证据水平:I 级。
Eur J Orthop Surg Traumatol. 2024-11-23
Cochrane Database Syst Rev. 2015-10-22
Cochrane Database Syst Rev. 2015-10-17
Cochrane Database Syst Rev. 2006-4-19
Eur J Orthop Surg Traumatol. 2025-5-9
J Clin Med. 2022-10-12
Sports Med Arthrosc Rev. 2022-6-1
Clin Geriatr Med. 2022-5
J Am Acad Orthop Surg. 2022-5-1